ABBV vs WT · P/E 81, rev $61.16B vs P/E 44, rev $427.7M
AbbVie Inc (ABBV) versus WisdomTree Inc. (WT) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
WisdomTree Inc. (WT) is a asset management company listed on NYSE.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported WT revenue for 2024-12-31 was $427.7M. Net income was $66.7M. Revenue was up 22.5% from 2023-12-31 to 2024-12-31. WT currently screens at market cap $2.78B and trailing P/E 44.3.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. WT currently screens at market cap $2.78B and trailing P/E 44.3.
Not investment advice. Open the ABBV and WT stock pages for the full models.
Not investment advice.